OA11077A - Paroxetine compositions - Google Patents

Paroxetine compositions Download PDF

Info

Publication number
OA11077A
OA11077A OA9900158A OA9900158A OA11077A OA 11077 A OA11077 A OA 11077A OA 9900158 A OA9900158 A OA 9900158A OA 9900158 A OA9900158 A OA 9900158A OA 11077 A OA11077 A OA 11077A
Authority
OA
OAPI
Prior art keywords
paroxetine hydrochloride
spray
dried
process according
paroxetine
Prior art date
Application number
OA9900158A
Other languages
English (en)
Inventor
Victor Witold Jacewicz
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9700692.8A external-priority patent/GB9700692D0/en
Priority claimed from GBGB9714873.8A external-priority patent/GB9714873D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of OA11077A publication Critical patent/OA11077A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
OA9900158A 1997-01-15 1999-07-15 Paroxetine compositions OA11077A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9700692.8A GB9700692D0 (en) 1997-01-15 1997-01-15 Novel process and compound
GBGB9714873.8A GB9714873D0 (en) 1997-07-15 1997-07-15 Novel process and compound

Publications (1)

Publication Number Publication Date
OA11077A true OA11077A (en) 2003-03-13

Family

ID=26310796

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9900158A OA11077A (en) 1997-01-15 1999-07-15 Paroxetine compositions

Country Status (21)

Country Link
US (1) US20010049442A1 (hu)
EP (1) EP0952831A1 (hu)
JP (1) JP2001508460A (hu)
KR (1) KR20000070151A (hu)
CN (1) CN1249686A (hu)
AP (1) AP9901604A0 (hu)
AU (1) AU730532B2 (hu)
BG (1) BG103648A (hu)
BR (1) BR9806754A (hu)
CA (1) CA2277480A1 (hu)
EA (1) EA002034B1 (hu)
HU (1) HUP0000960A3 (hu)
ID (1) ID23250A (hu)
IL (1) IL130856A (hu)
NO (1) NO993460L (hu)
NZ (1) NZ336587A (hu)
OA (1) OA11077A (hu)
PL (1) PL334568A1 (hu)
SK (1) SK95099A3 (hu)
TR (1) TR199901622T2 (hu)
WO (1) WO1998031365A1 (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9724544D0 (en) * 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
TR200100444T2 (tr) * 1998-08-07 2001-07-23 Smithkline Beecham P.L.C. Paroksetin Hidroklorid'in bir kristalin olmayan anhidrat formunun hazırlanma yöntemi
GB9824298D0 (en) * 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
JP4854115B2 (ja) 1999-03-12 2012-01-18 エイシカ ファーマシューティカルス リミテッド 無水パロキセチン用安定製剤形
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
ES2162560B1 (es) * 1999-06-25 2002-07-16 Rodriguez Concepcion Pena Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia.
PT1109806E (pt) 1999-07-01 2004-02-27 Italfarmaco Spa Complexos de paroxetina com ciclodextrinas ou derivados de ciclodextrinas
GB9919052D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel compound composition and process
GB9923439D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
US6660298B1 (en) * 2000-07-27 2003-12-09 Pentech Pharmaceuticals, Inc. Paroxetine tablets and capsules
IL154422A0 (en) * 2000-08-28 2003-09-17 Synthon Bv Paroxetine compositions and processes for making the same
US20060039975A1 (en) * 2004-08-20 2006-02-23 Zalman Vilkov Paroxetine formulations
CN104027306A (zh) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 帕罗西汀口服混悬液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2297550B (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride

Also Published As

Publication number Publication date
CA2277480A1 (en) 1998-07-23
EP0952831A1 (en) 1999-11-03
PL334568A1 (en) 2000-03-13
SK95099A3 (en) 2000-01-18
WO1998031365A1 (en) 1998-07-23
JP2001508460A (ja) 2001-06-26
NO993460L (no) 1999-09-14
CN1249686A (zh) 2000-04-05
AP9901604A0 (en) 1999-09-30
HUP0000960A2 (hu) 2001-02-28
AU5567398A (en) 1998-08-07
US20010049442A1 (en) 2001-12-06
BG103648A (en) 2000-04-28
KR20000070151A (ko) 2000-11-25
NO993460D0 (no) 1999-07-14
IL130856A (en) 2001-09-13
HUP0000960A3 (en) 2001-04-28
BR9806754A (pt) 2000-03-14
EA199900655A1 (ru) 2000-02-28
ID23250A (id) 2000-03-30
TR199901622T2 (xx) 1999-09-21
AU730532B2 (en) 2001-03-08
NZ336587A (en) 2001-01-26
EA002034B1 (ru) 2001-12-24
IL130856A0 (en) 2001-01-28

Similar Documents

Publication Publication Date Title
OA11077A (en) Paroxetine compositions
RU2125052C1 (ru) Ангидрат пароксетин гидрохлорида, сольваты пароксетин гидрохлорида и способы их получения
JP2002503248A (ja) 4−フェニルピペリジン化合物
WO2003013529A1 (en) Paroxetine glycyrrhizinate
MXPA03005888A (es) Base libre de amlodipina.
WO2000035873A1 (en) Process for preparation of paroxetine maleate
SK15032000A3 (sk) Maleínan paroxetínu, spôsob jeho výroby a jeho použitie
US20020002184A1 (en) Novel process and compound
JP2002507569A (ja) パロキセチン組成物
MXPA99006594A (en) Paroxetine compositions
WO2000027844A1 (en) Process for the preparation of paroxetine hydrochloride
JP2003502422A (ja) パロキセチンおよび構造上関連する化合物の製法
WO2000078288A2 (en) Novel process for paroxetine compositions
US20020028942A1 (en) Novel process and compound
EP1135384A1 (en) Process for the production of paroxetine hydrochloride propan-2-ol solvate
EP1155016A1 (en) Process for the production of paroxetine hydrochloride acetone solvate
WO2000032591A1 (en) Process for the preparation of paroxetine hydrochloride
CZ249799A3 (cs) Paroxetínová kompozice
JP2002531452A (ja) 混合パロキセチンプロパン−2−オール溶媒和物
JP2002531450A (ja) パロキセチン・塩酸塩の製造方法
JP2002533458A (ja) パロキセチン酢酸塩またはパロキセチンアナログの製造方法
WO2001012623A1 (en) Process for the preparation of paroxetine hydrochloride
JP2002533457A (ja) パロキセチン酢酸塩またはパロキセチンアナログの製造法
US20040143120A1 (en) Paroxetine maleate
JP2002533441A (ja) 酢酸パロキセチンおよびそのアナログの製造法